Povetacicept in IgA Nephropathy: What the RAINIER Phase 3 Safety Update and FDA Priority Review Actually Mean
Povetacicept’s latest RAINIER Phase 3 update matters for one specific reason: it improves confidence on short-term safety and regulatory momentum,…